Voiglim TRIO 2

Voiglim-TRIO-2 by Voithea Healthcare is a comprehensive anti-diabetic formulation containing Glimepiride 2mg, Metformin 500mg, and Pioglitazone 15mg, tailored for patients requiring intensive glycemic control. Glimepiride enhances pancreatic insulin secretion, Metformin reduces hepatic glucose output and improves insulin sensitivity, while Pioglitazone helps regulate glucose uptake and utilization in peripheral tissues.

This powerful triple combination is ideal for managing type 2 diabetes when monotherapy or dual therapy isn’t sufficient. Voiglim-TRIO-2 supports long-term glycemic stability and better metabolic health, reflecting Voithea Healthcare’s commitment to delivering innovative, effective, and patient-focused diabetic care solutions.